Area of research
Infectious Diseases · Clinical Biochemistry
Research interest
Research interests include Medicine, Clostridium difficile, Internal medicine, Tocilizumab, Dosing, and Cytokine release syndrome.
Dosing and Administration Strategies of Tocilizumab in Patients With COVID-19: A Retrospective Cohort Analysis
Efficacy and safety of commercialized fecal microbiota transplant for the treatment of recurrent Clostridioides difficile infection
Evaluation of a Capped Dosing Telavancin Regimen Compared to Standard Dosing at a Large Community Teaching Hospital
Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
Utilization and impact of a rapid Candida panel on antifungal stewardship program within a large community hospital
2622. Multiplex Polymerase Chain Reaction (PCR) Panels in Pediatric Hospital Care: New Insights into Factors Driving Antimicrobial Use
2425. Correlating Use of High-Risk Antimicrobials and the Incidence of Hospital-Onset Clostridium difficile Infection: Targeting Prescribing Trends for Antimicrobial Stewardship
256. Optimizing the Clinical Utilization of T2 Rapid Candida Panel at a Large Community Hospital
Successful use of fidaxomicin in recurrent Clostridium difficile infection in a child